Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography.
A simple reversed-phase liquid chromatographic method for the measurement of low concentrations of glibenclamide (glyburide) and its two major metabolites, 4-trans- and 3-cis-hydroxyglibenclamide, in human serum and urine has been developed. The compounds were extracted with n-hexane-dichloromethane (1:1). The UV detection wavelength was 203 nm. The minimum detectable serum level of glibenclamide was 1 ng ml (2 nM), and the relative standard deviation was 8.9% (n = 9). When maximum sensitivity was desired the metabolites were chromatographed separately. Metabolites in urine were measured by the same method after five-fold sample dilution. The utility of the method was tested on a healthy volunteer who ingested 3.5 mg of glibenclamide. The parent drug was present in the serum for at least 18 h, and the metabolites in the urine for at least 24 h.
Rydberg
T
T
Hospital Pharmacy, Lund University Hospital, Sweden.
Wåhlin-Boll
E
E
Melander
A
A
D000328:Adult; D002851:Chromatography, High Pressure Liquid / Q000379:methods* / Q000706:statistics & numerical data; D005905:Glyburide / Q000031:analogs & derivatives / Q000097:blood* / Q000493:pharmacokinetics / Q000652:urine; D006207:Half-Life; D006801:Humans; D008297:Male; D008832:Microchemistry
C070072:3-hydroxyglibenclamide; C070073:4-hydroxyglibenclamide; D005905:Glyburide